Pricing Log in Create free account

Jasper Therapeutics, Inc. (JSPR) vs Neuphoria Therapeutics Inc. (NEUP)

Jasper Therapeutics, Inc. and Neuphoria Therapeutics Inc. are both Biotechnology companies. Jasper Therapeutics, Inc. and Neuphoria Therapeutics Inc. are of similar size ($17.9M and $17.7M). Across the 9 metrics below, Neuphoria Therapeutics Inc. leads on 6 and Jasper Therapeutics, Inc. on 3.

Valuation

Metric JSPR NEUP Biotechnology median
P/E n/m n/m 8.50
P/S n/m 0.91 9.71
P/B 9.75 0.58 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m 0.27 0.64
EV/Sales n/m (0.30) 9.21
Earnings yield (331.25%) (154.60%) (33.15%)
Free cash flow yield (437.42%) (85.14%) (25.50%)

Profitability

Metric JSPR NEUP Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (255.05%) (61.70%) (56.36%)
Return on assets (109.05%) (46.95%) (48.04%)
Return on invested capital 0.00% (232.67%) 0.00%

Growth

Metric JSPR NEUP Biotechnology median
Revenue growth (TTM) — 3,535.05% 6.02%
EPS growth (last fiscal year) 19.22% (1,230.43%) 30.26%
Revenue growth, 5-year CAGR — 19.07% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric JSPR NEUP Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 1.48 27.85 4.72
Net debt to EBITDA 0.35 1.26 0.96

Dividend

Metric JSPR NEUP Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric JSPR NEUP Biotechnology median
Market cap 17.70m 17.91m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack